AstraZeneca Pharma Ind Share Price
ASTRAZEN
₹6,956.35+₹204.15 (3.02%) TodayLast updated on 22 Jan, 2025 | 15:43 IST
AstraZeneca Pharma Ind Share Price Chart
Please wait...
About AstraZeneca Pharma Ind
AstraZeneca Pharma Ind Financials
Market cap ₹16,881 Crs | Open ₹6,838.00 | Close ₹6,752.20 |
Circuit range ₹8,102.60 - ₹5,401.80 | Day range ₹6,619.50 - ₹7,099.90 | Year range ₹4,785.00 - ₹8,139.00 |
Volume 24,801 | Avg. traded ₹6,856.57 | Revenue (12m) ₹1,485 Crs |
AstraZeneca Pharma IndAstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).
Astrazeneca Pharma Ind Key indicators
52 week high ₹8,139.00 | 52 week low ₹4,785.00 | P/E ratio 206.09 |
P/B ratio 24.77 | ROE 24.95% | ROCE 33.94% |
Dividend yield 0.36% | Debt/Equity ratio | EPS 64.6 |
Learn more
Sector
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
AstraZeneca Pharma Ind Fundamentals
AstraZeneca Pharma Ind Financial Ratios
Operating profit margin16.84% | Net profit margin12.4% |
ROE24.95% | ROA13.35% |
ROCE33.94% |
Quick ratio1.74 | Current ratio2.23 |
Interest coverage183.95 | Asset turnover1.08 |
Debt to Equity0 |
P/E ratio206.09 | P/B ratio24.77 |
EV / EBITDA58.36 | |
Dividend yield0.36% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)Learn more
Cash flow
All values are in ₹ Crores (Cr)Learn more
Balance sheet
All values are in ₹ Crores (Cr)Total assets
Total liabilities
Learn more
Astrazeneca Pharma Ind Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Tue, Jan 21 2025 | ₹6,940.00 | ₹6,752.20 | -2.77% |
Mon, Jan 20 2025 | ₹6,865.65 | ₹6,944.70 | |
Fri, Jan 17 2025 | ₹6,859.00 | ₹6,920.30 | |
Thu, Jan 16 2025 | ₹6,746.30 | ₹6,785.50 | |
Wed, Jan 15 2025 | ₹7,120.00 | ₹6,735.90 | -4.23% |
Tue, Jan 14 2025 | ₹6,930.00 | ₹7,033.10 | -0.44% |
Mon, Jan 13 2025 | ₹6,750.05 | ₹7,063.90 | |
Fri, Jan 10 2025 | ₹7,067.30 | ₹6,907.35 | -2.56% |
Events
Corporate actions
Dividend • ₹24/share
Ex date 05 Jul 2024
Dividend • ₹16/share
Ex date 14 Jul 2023
Learn more
More
Stocks Similar to Astrazeneca Pharma Ind
Popular Stocks
AstraZeneca Pharma Ind News
FAQs on AstraZeneca Pharma Ind
What is the Astrazeneca Pharma Ind share price today?
Astrazeneca Pharma Ind share price is ₹ 6,956.35 today.
What is today’s high & low share price of Astrazeneca Pharma Ind?
Astrazeneca Pharma Ind share price high: ₹ 7,099.90 and low: ₹ 6,619.50
What is the Astrazeneca Pharma Ind share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 8,139.00 and Low Price is ₹ 4,785.00
What is the Astrazeneca Pharma Ind Stock Symbol?
The Astrazeneca Pharma Ind Stock symbol is ASTRAZEN.
Can I buy Astrazeneca Pharma Ind shares on Holidays?
No, shares of Astrazeneca Pharma Ind or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Astrazeneca Pharma Ind shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.